MEDICAL TECHNOLOGY M&A MARKET DYNAMICS
- M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024. However, activity was essentially flat compared to Q2 2025, representing a stabilization following consecutive quarterly declines.
- Strategic buyers remained the primary drivers of M&A activity this quarter, accounting for 58% of total deal volume, or 59 transactions.
- Activity was well distributed across subsectors, with the Therapeutic Device segment leading at 26% of total deals. Diagnostic (non-imaging) followed at 15%. The Consumable / Disposable, Contract Manufacturing, Equipment, and Service subsectors were all tied at approximately 11%. This mix reflects a balanced and diversified M&A landscape.
Medical Technology M&A Pulse – Q2 2025
M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.
Medical Technology M&A Pulse – Q1 2025
MEDICAL TECHNOLOGY M&A MARKET DYNAMICS M&A activity in the Medical Technology sector was relatively soft in Q1 2025, with 118 announced transactions, falling short of the 135 deals recorded in Q1 2024. To keep pace with the relatively stable deal volumes seen over the past three years on a yearly basis, the market will need…
Medical Technology M&A Pulse – Q4 2024
MedTech M&A deal volume in 2024 remained consistent with 2023 levels despite headwinds from rising input costs and regulatory shifts over the past year.
Medical Technology M&A Pulse – Q3 2024
Interest rate cuts bring a breath of fresh air to the Medical Technology sector, as more capital becomes available for acquisitions.
Medical Technology M&A Pulse – Q2 2024
Ongoing volatility in the Medical Technology M&A sector is driving heightened diligence and investor scrutiny to ensure acquisition targets are high-quality assets capable of withstanding current market turbulence.